As Dr Carlos Camps Herrero states, “innovation in oncology is no longer a question of if—but when.” In our conversation with Prof. Camps, we explore the barriers that still stand in the way of implementing transformative technologies such as AI, radiomics and molecular diagnostics. Dive into the full article to discover how we can bridge the gap between potential and real-world impact 👉 https://bit.ly/4nDHsor #Oncology #PrecisionMedicine #PublicHealth #AIinHealth #MedicalEducation #HealthInnovation
Advanced prostate cancer survival has tripled in the last 15 years, according to Sociedad Española de Oncología Médica (SEOM), thanks to: ➡️ Next-gen hormonal therapies ➡️ Novel chemotherapies and radioisotopes ➡️ PARP inhibitors for patients with BRCA1/2 mutations These advances are extending survival and improving quality of life through biomarker-guided, personalized strategies. At Quibim, we support this progress with QP-Prostate®, our AI-powered solution for earlier, more precise detection of aggressive prostate cancer. By standardizing interpretation and identifying lesions automatically, QP-Prostate® enables faster, more confident decisions in precision oncology. Innovation in diagnostics is saving lives. Let’s keep pushing forward. #ProstateCancer #PrecisionMedicine #AIinRadiology #MedicalImaging #QPProstate #OncologyInnovation #SEOM2025 #ImagingBiomarkers
In June, we participated in important discussions and listened closely to the needs of the clinical community. Through our presence at major industry events and the development of high-impact new features, we continued to work toward solutions that improve diagnostic accuracy, facilitate confident decision-making, and ultimately lead to better outcomes for patients. Stay up to date through our monthly newsletter 👇 #AIinHealthcare #Oncology #MedicalImaging #Innovation #PrecisionMedicine
We would like to thank everyone who joined our webinar endorsed by SERAM - Sociedad Española de Radiología Médica, 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐂𝐚𝐬𝐞 𝐒𝐞𝐬𝐬𝐢𝐨𝐧: 𝐀𝐈 𝐢𝐧 𝐩𝐫𝐨𝐬𝐭𝐚𝐭𝐞 𝐜𝐚𝐧𝐜𝐞𝐫 - 𝐕𝐨𝐥.2, where Dr. Fernando Losada from Argentina and Dr. Milagros Otero-García from Spain, shared real clinical cases and demonstrated how artificial intelligence is transforming daily medical practice. It was a valuable opportunity to explore real-life applications and discuss their impact on clinical decision making. If you were unable to attend live, you can watch the full session here: https://bit.ly/4493tDJ #Radiology #HealthcareInnovation #AI #MedicalImagin #QPProstate #webinar
We are proud to announce the launch of AI-QUAL™, an innovative new feature in our flagship QP-Prostate platform, designed to automate prostate MR image quality assessment using PI-QUAL v2 guidelines. Why is this a game changer? 🔹 Automated quality scoring to avoid manual checks 🔹 Standardized reporting for consistent image quality assessment, based on PI-QUAL v2 guidelines 🔹 Artifact detection to flag distortions such as rectal gas and metallic artifacts 🔹 Diagnostic confidence to empower radiologists with highest quality images 🔹 Seamless workflow integration With AI-QUAL, we're taking a giant leap forward in standardizing prostate MRI and support diagnostic accuracy. https://bit.ly/3Ieh04g #MedicalImaging #AIinHealthcare #ProstateCancer #DigitalHealth #PIQUAL #PIRADS #AIQUAL
Join us tomorrow for the second volume of our clinical case series: 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐂𝐚𝐬𝐞 𝐒𝐞𝐬𝐬𝐢𝐨𝐧: 𝐀𝐈 𝐢𝐧 𝐩𝐫𝐨𝐬𝐭𝐚𝐭𝐞 𝐜𝐚𝐧𝐜𝐞𝐫 - 𝐕𝐨𝐥.2 | 𝐖𝐞𝐛𝐢𝐧𝐚𝐫 𝐞𝐧𝐝𝐨𝐫𝐬𝐞𝐝 𝐛𝐲 𝐒𝐄𝐑𝐀𝐌 This webinar offers a unique opportunity to explore how artificial intelligence is advancing the diagnosis of #ProstateCancer through real-world clinical cases. Featuring expert insights from: • Dr. Milagros Otero-García, MD • Dr. Fernando Losada, MD 🗓️ Date: June 26 🕒 Time: 19:00 CEST / 14:00 GMT-3 📢 Language: Spanish 👉 Register now: https://bit.ly/4jZSIsk #Radiology #HealthcareInnovation #AI #MedicalImagin #QPProstate #webinar
🧠 Millions of people face every day a disease that, to this day, has no cure. Alzheimer's kills more people than breast and prostate cancer combined, and a new case of dementia is diagnosed every 3.2 seconds. It is time to talk, to prevent and to support research. #AlzheimersAndBrainAwarenessMonth #AlzheimersAwareness #BrainHealth #BrainMonth #Alzheimers #DementiaAwareness
📍 The #FLUTE consortium meeting is happening today in Barcelona, the goal: to advance the future of AI-powered #ProstateCancer imaging. Some of the main topics we are working on together: 🔹 Analyzing bpMRI and mpMRI scans from IRST, VHIR and CHUL using QP-Prostate, including lesion and gland segmentation. 🔹 Validation of synthetic MRI images created by UPC using QP-Prostate and radiomics. 🔹 Training radiologists to edit lesions with QP-Care. 🔹 Supporting Gradiant in the development of predictive models, a central goal of the project. Exciting progress and strong alignment between teams, looking forward to what's next! #AIinHealthcare #Radiology #MedicalImaging #Radiomics
🇭🇷 Promising updates from the RadioVal Consortium Meeting in Zagreb! We are integrating AI into the RadioVal clinical decision support system (powered by QP-Insights) with: ▪️ Automatic lesion segmentation ▪️ 3-year pCR and survival prediction ▪️ Continuous monitoring of model drift Quibim also leads the sustainability and exploitation strategy, which includes market analysis and assessment of the technology landscape to ensure long-term impact in #BreastCancer care. #AIinHealthcare #DigitalHealth #MedicalImaging
The 13th #ESUR prostate MRI course is being held today in Cambridge. Being close to clinical reality - and to the professionals who apply advanced imaging in practice - is essential to innovate with purpose. We are grateful that our team can hear directly from radiologists and oncologists to help us better understand their challenges, refine our solutions and make a meaningful contribution to #ProstateCancer care. #ProstateMRI #Oncology #MedicalImaging #Radiology #HealthTech #MedicalInnovation
